Tyramine Explained

Tyramine (also spelled tyramin), also known under several other names, is a naturally occurring trace amine derived from the amino acid tyrosine.[1] Tyramine acts as a catecholamine releasing agent. Notably, it is unable to cross the blood-brain barrier, resulting in only non-psychoactive peripheral sympathomimetic effects following ingestion. A hypertensive crisis can result, however, from ingestion of tyramine-rich foods in conjunction with the use of monoamine oxidase inhibitors (MAOIs).

Occurrence

Tyramine occurs widely in plants[2] and animals, and is metabolized by various enzymes, including monoamine oxidases. In foods, it often is produced by the decarboxylation of tyrosine during fermentation or decay. Foods that are fermented, cured, pickled, aged, or spoiled have high amounts of tyramine. Tyramine levels go up when foods are at room temperature or go past their freshness date.

Specific foods containing considerable amounts of tyramine include:[3] [4]

Scientists more and more consider tyramine in food as an aspect of safety.[6] They propose projects of regulations aimed to enact control of biogenic amines in food by various strategies, including usage of proper fermentation starters, or preventing their decarboxylase activity.[7] Some authors wrote that this has already given positive results, and tyramine content in food is now lower than it has been in the past.[8]

In plants

Mistletoe (toxic and not used by humans as a food, but historically used as a medicine).[9]

In animals

Tyramine also plays a role in animals including: In behavioral and motor functions in Caenorhabditis elegans; Locusta migratoria swarming behaviour; and various nervous roles in Rhipicephalus, Apis, Locusta, Periplaneta, Drosophila, Phormia, Papilio, Bombyx, Chilo, Heliothis, Mamestra, Agrotis, and Anopheles.

Physical effects and pharmacology

Evidence for the presence of tyramine in the human brain has been confirmed by postmortem analysis.[10] Additionally, the possibility that tyramine acts directly as a neuromodulator was revealed by the discovery of a G protein-coupled receptor with high affinity for tyramine, called TAAR1.[11] [12] The TAAR1 receptor is found in the brain, as well as peripheral tissues, including the kidneys.[13] Tyramine binds to TAAR1 as an agonist in humans.[14]

Tyramine is physiologically metabolized by monoamine oxidases (primarily MAO-A), FMO3, PNMT, DBH, and CYP2D6.[15] [16] Human monoamine oxidase enzymes metabolize tyramine into 4-hydroxyphenylacetaldehyde.[17] If monoamine metabolism is compromised by the use of monoamine oxidase inhibitors (MAOIs) and foods high in tyramine are ingested, a hypertensive crisis can result, as tyramine also can displace stored monoamines, such as dopamine, norepinephrine, and epinephrine, from pre-synaptic vesicles. Tyramine is considered a "false neurotransmitter", as it enters noradrenergic nerve terminals and displaces large amounts of norepinephrine, which enters the blood stream and causes vasoconstriction.

Additionally, cocaine has been found to block blood pressure rise that is originally attributed to tyramine, which is explained by the blocking of adrenaline by cocaine from reabsorption to the brain.[18]

The first signs of this effect were discovered by a British pharmacist who noticed that his wife, who at the time was on MAOI medication, had severe headaches when eating cheese.[19] For this reason, it is still called the "cheese reaction" or "cheese crisis", although other foods can cause the same problem.[20]

Most processed cheeses do not contain enough tyramine to cause hypertensive effects, although some aged cheeses (such as Stilton) do.[21] [22]

A large dietary intake of tyramine (or a dietary intake of tyramine while taking MAO inhibitors) can cause the tyramine pressor response, which is defined as an increase in systolic blood pressure of 30 mmHg or more. The increased release of norepinephrine (noradrenaline) from neuronal cytosol or storage vesicles is thought to cause the vasoconstriction and increased heart rate and blood pressure of the pressor response. In severe cases, adrenergic crisis can occur. Although the mechanism is unclear, tyramine ingestion also triggers migraine attacks in sensitive individuals and can even lead to stroke.[23] Vasodilation, dopamine, and circulatory factors are all implicated in the migraines. Double-blind trials suggest that the effects of tyramine on migraine may be adrenergic.[24]

Research reveals a possible link between migraines and elevated levels of tyramine. A 2007 review published in Neurological Sciences[25] presented data showing migraine and cluster diseases are characterized by an increase of circulating neurotransmitters and neuromodulators (including tyramine, octopamine, and synephrine) in the hypothalamus, amygdala, and dopaminergic system. People with migraine are over-represented among those with inadequate natural monoamine oxidase, resulting in similar problems to individuals taking MAO inhibitors. Many migraine attack triggers are high in tyramine.[26]

If one has had repeated exposure to tyramine, however, there is a decreased pressor response; tyramine is degraded to octopamine, which is subsequently packaged in synaptic vesicles with norepinephrine (noradrenaline). Therefore, after repeated tyramine exposure, these vesicles contain an increased amount of octopamine and a relatively reduced amount of norepinephrine. When these vesicles are secreted upon tyramine ingestion, there is a decreased pressor response, as less norepinephrine is secreted into the synapse, and octopamine does not activate alpha or beta adrenergic receptors.

When using a MAO inhibitor (MAOI), an intake of approximately 10 to 25 mg of tyramine is required for a severe reaction, compared to 6 to 10 mg for a mild reaction.[27]

Tyramine, like phenethylamine, is a monoaminergic activity enhancer (MAE) of serotonin, norepinephrine, and dopamine in addition to its catecholamine-releasing activity.[28] [29] [30] That is, it enhances the action potential-mediated release of these monoamine neurotransmitters. The compound is active as a MAE at much lower concentrations than the concentrations at which it induces the release of catecholamines. The MAE actions of tyramine and other MAEs may be mediated by TAAR1 agonism.[31] [32]

Biosynthesis

Biochemically, tyramine is produced by the decarboxylation of tyrosine via the action of the enzyme tyrosine decarboxylase.[33] Tyramine can, in turn, be converted to methylated alkaloid derivatives N-methyltyramine, N,N-dimethyltyramine (hordenine), and N,N,N-trimethyltyramine (candicine).

In humans, tyramine is produced from tyrosine, as shown in the following diagram.

Chemistry

In the laboratory, tyramine can be synthesized in various ways, in particular by the decarboxylation of tyrosine.[34] [35] [36]

Society and culture

Legal status

United States

Tyramine is a Schedule I controlled substance, categorized as a hallucinogen, making it illegal to buy, sell, or possess in the state of Florida without a license at any purity level or any form whatsoever. The language in the Florida statute says tyramine is illegal in "any material, compound, mixture, or preparation that contains any quantity of [tyramine] or that contains any of [its] salts, isomers, including optical, positional, or geometric isomers, and salts of isomers, if the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation."[37]

This ban is likely the product of lawmakers overly eager to ban substituted phenethylamines, which tyramine is, in the mistaken belief that ring-substituted phenethylamines are hallucinogenic drugs like the 2C series of psychedelic substituted phenethylamines. The further banning of tyramine's optical isomers, positional isomers, or geometric isomers, and salts of isomers where they exist, means that meta-tyramine and phenylethanolamine, a substance found in every living human body, and other common, non-hallucinogenic substances are also illegal to buy, sell, or possess in Florida.[37] Given that tyramine occurs naturally in many foods and drinks (most commonly as a by-product of bacterial fermentation), e.g. wine, cheese, and chocolate, Florida's total ban on the substance may prove difficult to enforce.[38]

Notes and References

  1. Web site: tyramine C8H11NO. PubChem. en. 2017-04-08.
  2. T. A. Smith (1977) Phytochemistry 16 9–18.
  3. Web site: Hall-Flavin DK . Avoid the combination of high-tyramine foods and MAOIs . Mayo Clinic . en . 18 December 2018.
  4. Web site: Robinson J . Tyramine-Rich Foods As A Migraine Trigger & Low Tyramine Diet . WebMD . en . 21 June 2020.
  5. Web site: Tyramine . pubchem.ncbi.nlm.nih.gov . en.
  6. Martuscelli M, Esposito L, Mastrocola D . Biogenic Amines' Content in Safe and Quality Food . Foods . 10 . 1 . 100 . January 2021 . 33418895 . 7825060 . 10.3390/foods10010100 . free .
  7. Scientific Opinion on risk based control of biogenic amine formation in fermented foods . EFSA Journal . 2011 . 9 . 10 . 2393 . 10.2903/j.efsa.2011.2393 . free .
  8. Book: 10.1016/B978-0-12-386467-3.00009-1 . Selective inhibitors of monoamine oxidase type B and the "cheese effect" . Monoamine Oxidase and their Inhibitors . International Review of Neurobiology . 2011 . Finberg JP, Gillman K . 100 . 169–190 . 21971008 . 978-0-12-386467-3 .
  9. Web site: 19 December 2005 . Tyramine . American Chemical Society . en.
  10. Philips SR, Rozdilsky B, Boulton AA . Evidence for the presence of m-tyramine, p-tyramine, tryptamine, and phenylethylamine in the rat brain and several areas of the human brain . Biological Psychiatry . 13 . 1 . 51–7 . February 1978 . 623853 .
  11. Navarro HA, Gilmour BP, Lewin AH . A rapid functional assay for the human trace amine-associated receptor 1 based on the mobilization of internal calcium . Journal of Biomolecular Screening . 11 . 6 . 688–93 . September 2006 . 16831861 . 10.1177/1087057106289891 . free .
  12. Liberles SD, Buck LB . A second class of chemosensory receptors in the olfactory epithelium . Nature . 442 . 7103 . 645–50 . August 2006 . 16878137 . 10.1038/nature05066 . 2864195 . 2006Natur.442..645L .
  13. Xie Z, Westmoreland SV, Miller GM . Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes . The Journal of Pharmacology and Experimental Therapeutics . 325 . 2 . 629–640 . May 2008 . 18310473 . 10.1124/jpet.107.135079 . 178180 .
  14. Khan MZ, Nawaz W . The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system . Biomedicine & Pharmacotherapy . 83 . 439–449 . October 2016 . 27424325 . 10.1016/j.biopha.2016.07.002 .
  15. Encyclopedia: Trimethylamine monooxygenase (Homo sapiens). BRENDA . Technische Universität Braunschweig . 18 September 2016 . July 2016 .
  16. Krueger SK, Williams DE . Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism . Pharmacology & Therapeutics . 106 . 3 . 357–87 . June 2005 . 15922018 . 1828602 . 10.1016/j.pharmthera.2005.01.001 .
    Table 5: N-containing drugs and xenobiotics oxygenated by FMO
  17. Web site: 4-Hydroxyphenylacetaldehyde . Human Metabolome Database – Version 4.0 . University of Alberta . 8 August 2019 . 2019-07-23.
  18. News: . Bynum W . REVIEW --- Books: What Sets Your Heart Pounding . Wall Street Journal . 27 April 2013 . C.6 .
  19. Sathyanarayana Rao TS, Yeragani VK . Hypertensive crisis and cheese . Indian Journal of Psychiatry . 51 . 1 . 65–6 . January 2009 . 19742203 . 2738414 . 10.4103/0019-5545.44910 . free .
  20. Web site: Drugs, The Straight Facts: Antidepressants . 30–31 . Mitchell ES . Triggle DJ . . dead . https://web.archive.org/web/20170214224003/http://iftandcs.org/Addictions/Drugs%20The%20Straight%20Facts,%20Antidepressants.pdf . 2017-02-14 . 2004 . 2022-10-06.
  21. Stahl SM, Felker A . Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants . CNS Spectrums . 13 . 10 . 855–870 . October 2008 . 18955941 . 10.1017/S1092852900016965 . 6118722 .
  22. Web site: Tyramine-restricted Diet . https://web.archive.org/web/20140513145012/http://web.squ.edu.om/med-lib/med_cd/e_cds/Griffith's%20Instructions%20Patients/pdf/Pg570.pdf . 13 May 2014 . 1998 . W.B. Saunders Company .
  23. Encyclopedia: Tyramine . Biochemistry . Encyclopedia Britannica. 2021-11-12 . en.
  24. Ghose K, Coppen A, Carrol D . Intravenous tyramine response in migraine before and during treatment with indoramin . British Medical Journal . 1 . 6070 . 1191–3 . May 1977 . 324566 . 1606859 . 10.1136/bmj.1.6070.1191 .
  25. D'Andrea G, Nordera GP, Perini F, Allais G, Granella F . Biochemistry of neuromodulation in primary headaches: focus on anomalies of tyrosine metabolism . Neurological Sciences . 28 . S2 . S94-6 . May 2007 . 17508188 . 10.1007/s10072-007-0758-4 . 1548732 .
  26. News: Headache Sufferer's Diet National Headache Foundation. National Headache Foundation. 2017-04-08. en-US. https://web.archive.org/web/20170702160059/http://www.headaches.org/headache-sufferers-diet. 2 July 2017. dead.
  27. McCabe BJ . Dietary tyramine and other pressor amines in MAOI regimens: a review . Journal of the American Dietetic Association . 86 . 8 . 1059–64 . August 1986 . 10.1016/S0002-8223(21)04074-8 . 3525654 . 902921 .
  28. Shimazu S, Miklya I . Pharmacological studies with endogenous enhancer substances: beta-phenylethylamine, tryptamine, and their synthetic derivatives . Progress in Neuro-Psychopharmacology & Biological Psychiatry . 28 . 3 . 421–427 . May 2004 . 15093948 . 10.1016/j.pnpbp.2003.11.016 . 37564231 .
  29. Knoll J . Enhancer regulation/endogenous and synthetic enhancer compounds: a neurochemical concept of the innate and acquired drives . Neurochem Res . 28 . 8 . 1275–1297 . August 2003 . 12834268 . 10.1023/a:1024224311289 .
  30. Knoll J, Miklya I, Knoll B, Markó R, Rácz D . Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain . Life Sci . 58 . 23 . 2101–2114 . 1996 . 8649195 . 10.1016/0024-3205(96)00204-4 .
  31. Harsing LG, Knoll J, Miklya I . Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum . Int J Mol Sci . 23 . 15 . August 2022 . 8543 . 35955676 . 9369307 . 10.3390/ijms23158543 . free .
  32. Harsing LG, Timar J, Miklya I . Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline . Int J Mol Sci . 24 . 17 . August 2023 . 13334 . 37686140 . 10487936 . 10.3390/ijms241713334 . free .
  33. Encyclopedia: Tyrosine metabolism - Reference pathway . Kyoto Encyclopedia of Genes and Genomes (KEGG) . 3 October 2011 . 26 July 2019 . https://web.archive.org/web/20190726082244/http://www.genome.jp/kegg/pathway/map/map00350.html . dead .
  34. Barger G . J. Chem. Soc. . 95 . 1123–1128 . 1909 . 10.1039/ct9099501123 . CXXVII.?Isolation and synthesis of p-hydroxyphenylethylamine, an active principle of ergot soluble in water.
  35. 10.1002/hlca.192500801106 . Untersuchungen in der Phenylalanin-Reihe VI. Decarboxylierung des Tyrosins und des Leucins . 1925 . Waser E . Helvetica Chimica Acta . 8 . 758–773.
  36. 10.1021/ja01335a058 . 1933 . Buck JS . Journal of the American Chemical Society . 55 . 8 . 3388–3390 . Reduction of Hydroxymandelonitriles. A New Synthesis of Tyramine.
  37. Web site: Statutes & Constitution :View Statutes : Online Sunshine. leg.state.fl.us. 2019-04-03.
  38. Suzzi G, Torriani S . Editorial: Biogenic amines in foods . Frontiers in Microbiology . 6 . 472 . 2015-05-18 . 26042107 . 4435245 . 10.3389/fmicb.2015.00472 . free .